Bridging non-human primate correlates of protection to reassess the Anthrax Vaccine Adsorbed booster schedule in humans

Anthrax Vaccine Adsorbed (AVA, BioThrax®) is approved for use in humans as a priming series of 3 intramuscular (i.m.) injections (0, 1, 6 months; 3-IM) with boosters at 12 and 18 months, and annually thereafter for those at continued risk of infection. A reduction in AVA booster frequency would less...

Descripción completa

Detalles Bibliográficos
Autores principales: Schiffer, Jarad M., Chen, Ligong, Dalton, Shannon, Niemuth, Nancy A., Sabourin, Carol L., Quinn, Conrad P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360524/
https://www.ncbi.nlm.nih.gov/pubmed/26072016
http://dx.doi.org/10.1016/j.vaccine.2015.05.091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360524/
https://www.ncbi.nlm.nih.gov/pubmed/26072016
http://dx.doi.org/10.1016/j.vaccine.2015.05.091

Ejemplares similares